Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sotyktu + Enstilar for Plaque Psoriasis
NCT06329258Phase 4Completed
- Sponsor
- Psoriasis Treatment Center of Central New Jersey
- Start
- Dec 2022
- Primary completion
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of deucravacitinib in plaque psoriasis, sponsored by Psoriasis Treatment Center of Central New Jersey. Started Dec 2022; status: completed.
02
Drugs
deucravacitinib
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT06329258.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06329258.